AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Patrys Ltd

0.028

0.000

Volume:- -

Turnover:- -

Market Cap:9.55M

PE:-1.60

High:0.028

Open:0.028

Low:0.028

Close:0.028

52wk High:0.060

52wk Low:0.015

Shares:341.00M

Float Shares:183.00M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.017

EPS(LYR):-0.018

ROE:-143.39%

ROA:-57.40%

PB:13.03

PE(LYR):-1.56

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Patrys Ltd

Exchange:

ASX

Establishment Date:

2006

Employees:

10

Office Location:

168 Stirling Highway,Nedlands,Western Australia,Australia

Website:

http://www.patrys.com

Zip Code:

6009

Phone:

Fax:

- -

Introduction:

Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PAB.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PAB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","market":"AU","secType":"STK","nameCN":"Patrys Ltd","latestPrice":0.028,"timestamp":1766466720000,"preClose":0.028,"halted":0,"volume":0,"delay":0,"nameEN":"Patrys Ltd","floatShares":183000000,"shares":341000000,"eps":-0.0175,"marketStatus":"Closed","change":0,"latestTime":"12-23 16:12:00 AEDT","open":0.028,"high":0.028,"low":0.028,"amount":0,"amplitude":0,"askPrice":0.03,"askSize":264242,"bidPrice":0.028,"bidSize":102184,"shortable":3,"etf":0,"ttmEps":-0.0175,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766530800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.028,"openAndCloseTimeList":[[1766444400000,1766466000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PAB.AU\",,,,,undefined,":{"symbol":"PAB.AU","floatShares":183000000,"roa":"-57.40%","roe":"-143.39%","lyrEps":-0.018,"shares":341000000,"dividePrice":0,"high":0.028,"amplitude":0,"preClose":0.028,"low":0.028,"week52Low":0.015,"pbRate":"13.03","psRate":"11.52","week52High":0.06,"institutionHeld":0,"latestPrice":0.028,"committee":-0.442267,"eps":-0.0175,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.0175,"open":0.028,"prevYearClose":0.06,"prevWeekClose":0.027,"prevMonthClose":0.03,"prevQuarterClose":0.03,"fiveDayClose":0.028,"twentyDayClose":0.035,"sixtyDayClose":0.03,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PAB.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-10-13","symbol":"PAB.AU","defaultRemindTime":1760310000000,"type":"split","dateTimestamp":1760274000000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"AU","date":"2021-11-03","symbol":"PAB.AU","defaultRemindTime":1635894000000,"type":"split","dateTimestamp":1635858000000,"forFactor":995841,"toFactor":1000000,"ratio":0.9958410000000001},{"market":"AU","date":"2020-11-11","symbol":"PAB.AU","type":"split","dateTimestamp":1605013200000,"forFactor":2147483647,"toFactor":2147483647,"ratio":0.99319}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PAB.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":35109071,"yearFounded":2006,"employeeNum":10,"address":"168 Stirling Highway,Nedlands,Western Australia,Australia","zipCode":"6009","officePhone":"61 8 6165 8858"},"stockCompanyDetail":{"websiteUrl":"http://www.patrys.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.2},{"period":"3month","weight":-0.0667},{"period":"6month","weight":0.8667},{"period":"1year","weight":-0.5333},{"period":"ytd","weight":-0.5333}],"compareEarnings":[{"period":"1week","weight":0.0271},{"period":"1month","weight":0.0456},{"period":"3month","weight":0.0595},{"period":"6month","weight":0.0983},{"period":"1year","weight":0.2726},{"period":"ytd","weight":0.2594}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates live cell nuclei and inhibits mechanisms of DNA repair in target cancer cells. The company also focuses on developing PAT-DX1 as a treatment for metastatic triple negative breast cancer and glioblastoma. In addition, it engages in developing PAT-SC1's target/antigen CD55PAT-SC1, an isoform of the membrane-bound CD55 for the treatment of gastric cancer. Patrys Limited was founded in 2006 and is based in South Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.277778,"avgChangeRate":-0.028089},{"month":2,"riseRate":0.5,"avgChangeRate":-0.022957},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.042963},{"month":4,"riseRate":0.388889,"avgChangeRate":-0.044949},{"month":5,"riseRate":0.222222,"avgChangeRate":0.01782},{"month":6,"riseRate":0.277778,"avgChangeRate":0.091791},{"month":7,"riseRate":0.157895,"avgChangeRate":-0.099901},{"month":8,"riseRate":0.473684,"avgChangeRate":0.290084},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.007469},{"month":10,"riseRate":0.421053,"avgChangeRate":0.040395},{"month":11,"riseRate":0.210526,"avgChangeRate":-0.026724},{"month":12,"riseRate":0.388889,"avgChangeRate":-0.030686}],"exchange":"ASX","name":"Patrys Ltd","nameEN":"Patrys Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PAB.AU\",market:\"AU\",,,undefined,":null}}